Search Results

Display Settings
Results per page: 10
Sort By: Date Descending
Filter
  • 1-10 of  790,921 results for ""ANTINEOPLASTIC agents""

Your Filters

Filter by : Subject Sort Order : Publication Date Descending
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma.

  • Authors : Numakura K; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.; Igarashi R

Subjects: Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/drug therapy ; Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/genetics ; Kidney Neoplasms*/Kidney Neoplasms*/Kidney Neoplasms*/drug therapy

  • Source: Cancer biology & therapy [Cancer Biol Ther] 2024 Dec 31; Vol. 25 (1), pp. 2312602. Date of Electronic Publication: 2024 Feb 07.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells.

  • Authors : Wang H; Department of Medicine, University of Washington, Seattle, WA, USA.; Koob T

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/pathology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use

  • Source: Cancer biology & therapy [Cancer Biol Ther] 2024 Dec 31; Vol. 25 (1), pp. 2314322. Date of Electronic Publication: 2024 Feb 15.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma.

  • Authors : Pirosa MC; Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Institute of Oncology Research, Bellinzona, Switzerland.

Subjects: Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/etiology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2309701. Date of Electronic Publication: 2024 Feb 01.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Agricultural wastes: a new promising source for phenylalanine ammonia-lyase as anticancer agent.

Subjects: AGRICULTURAL wastes; ANTINEOPLASTIC agents; PHENYLALANINE

  • Source: 3 Biotech; 12/26/2023, Vol. 14 Issue 1, p1-11, 11p

Record details

Read More Add to Saved list
×
Academic Journal

Shenqi Fuzheng injection restores the sensitivity to gefitinib in non-small cell lung cancer by inhibiting the IL-22/STAT3/AKT pathway.

  • Authors : Wang J; School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.; He X

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/genetics

  • Source: Pharmaceutical biology [Pharm Biol] 2024 Dec; Vol. 62 (1), pp. 33-41. Date of Electronic Publication: 2023 Dec 15.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9812552 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Connect Read More Add to Saved list
×
Academic Journal

Design, synthesis and biological evaluation of novel podophyllotoxin derivatives as tubulin-targeting anticancer agents.

  • Authors : Guo Y; Institute of Clinical Pharmacy, Jining First People's Hospital, Shandong First Medical University, Jining, P.R. China.; Translational Pharmaceutical Laboratory, Jining First People's Hospital, Shandong First Medical University, Jining, P.R. China.

Subjects: Podophyllotoxin*/Podophyllotoxin*/Podophyllotoxin*/pharmacology ; Podophyllotoxin*/Podophyllotoxin*/Podophyllotoxin*/chemistry ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology

  • Source: Pharmaceutical biology [Pharm Biol] 2024 Dec; Vol. 62 (1), pp. 233-249. Date of Electronic Publication: 2024 Feb 23.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9812552 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Connect Read More Add to Saved list
×
Academic Journal

Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.

  • Authors : Li J; Department of Traditional Chinese Medicine, The First People's Hospital of Lin'an District, Hangzhou, China.; Ma X

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/drug therapy

  • Source: Pharmaceutical biology [Pharm Biol] 2024 Dec; Vol. 62 (1), pp. 314-325. Date of Electronic Publication: 2024 Apr 04.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9812552 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Connect Read More Add to Saved list
×
Academic Journal

Studying the effects of secondary metabolites isolated from Cycas thouarsii R.Br. leaves on MDA-MB-231 breast cancer cells.

  • Authors : Alotaibi B; Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.; A El-Masry T

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Cycas* ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology

  • Source: Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2024 Dec; Vol. 52 (1), pp. 103-113. Date of Electronic Publication: 2024 Jan 27.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101594777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Connect Read More Add to Saved list
×
Academic Journal

The oncological and reproductive outcomes of fertility-preserving treatments for stage 1 grade 1 endometrial carcinoma: a systematic review and meta-analysis.

  • Authors : Ogunbiyi MO; University College London Hospitals NHS Foundation Trust, London, UK.; Oxley S

Subjects: Fertility Preservation* ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/surgery ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/drug therapy

  • Source: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology [J Obstet Gynaecol] 2024 Dec; Vol. 44 (1), pp. 2294329. Date of Electronic Publisher: Informa Healthcare Country of Publication: England NLM ID: 8309140 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

9,10-Dioxoanthracenyldithiocarbamates effectively inhibit the proliferation of non-small cell lung cancer by targeting multiple protein tyrosine kinases.

  • Authors : Olszewski M; Department of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdansk University of Technology, Gdansk, Poland.; Stasevych M

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/metabolism ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy

  • Source: Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2024 Dec; Vol. 39 (1), pp. 2284113. Date of Electronic Publication: 2023 Dec 11.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101150203 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Connect Read More Add to Saved list
×
  • 1-10 of  790,921 results for ""ANTINEOPLASTIC agents""